223 related articles for article (PubMed ID: 27964905)
1. ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer.
Davis BJ; Taira AV; Nguyen PL; Assimos DG; D'Amico AV; Gottschalk AR; Gustafson GS; Keole SR; Liauw SL; Lloyd S; McLaughlin PW; Movsas B; Prestidge BR; Showalter TN; Vapiwala N
Brachytherapy; 2017; 16(2):266-276. PubMed ID: 27964905
[TBL] [Abstract][Full Text] [Related]
2. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy.
Davis BJ; Horwitz EM; Lee WR; Crook JM; Stock RG; Merrick GS; Butler WM; Grimm PD; Stone NN; Potters L; Zietman AL; Zelefsky MJ;
Brachytherapy; 2012; 11(1):6-19. PubMed ID: 22265434
[TBL] [Abstract][Full Text] [Related]
3. ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer.
Hsu IC; Yamada Y; Assimos DG; D'Amico AV; Davis BJ; Frank SJ; Gottschalk AR; Gustafson GS; McLaughlin PW; Nguyen PL; Rosenthal SA; Taira AV; Vapiwala N; Merrick G
Brachytherapy; 2014; 13(1):27-31. PubMed ID: 24368283
[TBL] [Abstract][Full Text] [Related]
4. American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer.
; Frank SJ; Arterbery VE; Hsu IC; Abdel-Wahab M; Ciezki JP; Hahn NM; Mohler JL; Moran BJ; Rosenthal SA; Rossi CJ; Yamada Y; Merrick G
Brachytherapy; 2011; 10(5):357-62. PubMed ID: 21497562
[TBL] [Abstract][Full Text] [Related]
5. ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer.
Moran BJ; DeRose P; Hsu IC; Abdel-Wahab M; Arterbery VE; Ciezki JP; Frank SJ; Mohler JL; Rosenthal SA; Rossi CJ; Yamada Y; Merrick GS
Am J Clin Oncol; 2011 Dec; 34(6):636-47. PubMed ID: 22101389
[TBL] [Abstract][Full Text] [Related]
6. ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer.
Nguyen PL; Aizer A; Assimos DG; D'Amico AV; Frank SJ; Gottschalk AR; Gustafson GS; Hsu IC; McLaughlin PW; Merrick G; Rosenthal SA; Showalter TN; Taira AV; Vapiwala N; Yamada Y; Davis BJ;
Am J Clin Oncol; 2014 Jun; 37(3):278-88. PubMed ID: 25180754
[TBL] [Abstract][Full Text] [Related]
7. The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer.
Bittner NH; Orio PF; Merrick GS; Prestidge BR; Hartford AC; Rosenthal SA
Brachytherapy; 2017; 16(1):59-67. PubMed ID: 28109632
[TBL] [Abstract][Full Text] [Related]
8. American College of Radiology Appropriateness Criteria(®)--locally advanced (high-risk) prostate cancer.
Ciezki JP; Hsu IC; Abdel-Wahab M; Arterbery VE; Frank SJ; Mohler JL; Moran BJ; Rosenthal SA; Rossi CJ; Yamada Y; Merrick G;
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):43-51. PubMed ID: 21875782
[TBL] [Abstract][Full Text] [Related]
9. ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer.
McLaughlin PW; Liss AL; Nguyen PL; Assimos DG; D'Amico AV; Gottschalk AR; Gustafson GS; Keole SR; Liauw SL; Lloyd S; Movsas B; Prestidge BR; Showalter TN; Taira AV; Vapiwala N; Davis BJ;
Am J Clin Oncol; 2017 Feb; 40(1):1-10. PubMed ID: 28059930
[TBL] [Abstract][Full Text] [Related]
10. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer.
Nag S; Beyer D; Friedland J; Grimm P; Nath R
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):789-99. PubMed ID: 10386635
[TBL] [Abstract][Full Text] [Related]
11. ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer.
Gustafson GS; Nguyen PL; Assimos DG; D'Amico AV; Gottschalk AR; Hsu IC; Lloyd S; Mclaughlin PW; Merrick GS; Showalter TN; Taira AV; Vapiwala N; Yamada Y; Davis BJ
Oncology (Williston Park); 2014 Dec; 28(12):1125-30, 1132-6. PubMed ID: 25510812
[TBL] [Abstract][Full Text] [Related]
12. ACR Appropriateness Criteria® external-beam radiation therapy treatment planning for clinically localized prostate cancer.
Abdel-Wahab M; Mahmoud O; Merrick G; Hsu IC; Arterbery VE; Ciezki JP; Frank SJ; Mohler JL; Moran BJ; Rosenthal SA; Rossi CJ; Yamada Y
J Am Coll Radiol; 2012 Apr; 9(4):233-8. PubMed ID: 22469373
[TBL] [Abstract][Full Text] [Related]
13. A simple method for dose fusion from multimodality treatment of prostate cancer: brachytherapy to external beam therapy.
Cao M; Ko SC; Slessinger ED; DesRosiers CM; Johnstone PA; Das IJ
Brachytherapy; 2011; 10(3):214-20. PubMed ID: 20843747
[TBL] [Abstract][Full Text] [Related]
14. ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer.
Bittner NHJ; Cox BW; Davis B; King M; Lawton CAF; Merrick GS; Orio P; Ouhib Z; Rossi P; Showalter T; Small W; Schechter NR
Am J Clin Oncol; 2022 Jun; 45(6):249-257. PubMed ID: 35588224
[TBL] [Abstract][Full Text] [Related]
15. ACR Appropriateness Criteria
; Coakley FV; Oto A; Alexander LF; Allen BC; Davis BJ; Froemming AT; Fulgham PF; Hosseinzadeh K; Porter C; Sahni VA; Schuster DM; Showalter TN; Venkatesan AM; Verma S; Wang CL; Remer EM; Eberhardt SC
J Am Coll Radiol; 2017 May; 14(5S):S245-S257. PubMed ID: 28473080
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Dose and Quality Assurance in Early Prostate Cancer Treated with Low Dose Rate Brachytherapy as Monotherapy.
Henry AM; Rodda SL; Mason M; Musunuru H; Al-Qaisieh B; Bownes P; Smith J; Franks K; Carey B; Bottomley D
Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):382-6. PubMed ID: 25805312
[TBL] [Abstract][Full Text] [Related]
18. Acr appropriateness Criteria management of vaginal cancer.
Lee LJ; Jhingran A; Kidd E; Cardenes HR; Elshaikh MA; Erickson B; Mayr NA; Moore D; Puthawala AA; Rao GG; Small W; Varia MA; Wahl AO; Wolfson AH; Yashar CM; Yuh W; Gaffney DK
Oncology (Williston Park); 2013 Nov; 27(11):1166-73. PubMed ID: 24575547
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.
Bowes D; Crook JM; Araujo C; Batchelar D
Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473
[TBL] [Abstract][Full Text] [Related]
20. Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experience.
Henry AM; Al-Qaisieh B; Gould K; Bownes P; Smith J; Carey B; Bottomley D; Ash D
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):50-6. PubMed ID: 20005453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
